Bulletin from the annual general meeting of Qlucore AB (publ)
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
The annual general meeting in Qlucore AB (publ) was held today, September 10, 2024, whereby the shareholders made the following decisions.
Approval of the income statement and balance sheet
The annual general meeting approved the income statement and balance sheet as well as the consolidated income statement and consolidated balance sheet.
Profit
The annual general meeting decided to allocate the profit in accordance with the Board of Directors’ proposal in the annual report, that the profit will be carried forward.
Discharge from liability
The members of the Board of Directors and the company’s CEO were discharged from liability for the period 1 May 2023 to 30 April 2024.
Board of Directors, External Auditor and fees and compensation
In accordance with the Nomination Committee's proposal, Pia Gideon (Chairman), Magnus Fontes, Thoas Fioretos, Carl-Johan Ivarsson, Boel Sundvall, Helle Fisker and Lars Höckenström was re-elected as members of the Board of Directors.
The annual general meeting decided, in accordance with the nomination committee's proposal, to re-elect the audit company, PWC for the period until the end of the 2025 annual general meeting.
Furthermore, in accordance with the nomination committee's proposal, unchanged remuneration was decided for the members of the board as follows:
- 110,000 SEK to board member and 264,000 SEK to the Chairman
- 30,000 SEK to distribute between the members of the audit committee
- The CEO receives no remuneration
It was decided, in accordance with the Nomination Committee's proposal, that auditors' fees should be paid in accordance with approved invoices.
Nomination Committee
The annual general meeting decided, in accordance with the nomination committee's proposal, to adopt the principles for appointing a nomination committee.